Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Continuous Intra-Arterial Nimodipine for the Treatment of Cerebral Vasospasm

Journal Article · · Cardiovascular and Interventional Radiology
; ;  [1];  [2];  [3];  [4]
  1. University of Munich (LMU), Department of Neurology, Klinikum Grosshadern (Germany)
  2. University of Munich (LMU), Department of Neuroradiology, Klinikum Grosshadern (Germany)
  3. Dr. Horst Schmidt Klinik, Wiesbaden, Department of Neurology (Germany)
  4. University Hospital, Department of Radiology (Germany)
Two patients with refractory symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) were treated by continuous intra-arterial nimodipine infusion via a catheter placed in the internal carotid artery or vertebral artery for 3 and 12 days, respectively. Recovery of the neurological deficits, normalization of MR perfusion, a decrease in the elevated mean flow velocity measured by transcranial duplex sonography, and angiographic recanalization were observed. Continuous intra-arterial nimodipine might be a treatment option in severe refractory vasospasm following SAH.
OSTI ID:
21426344
Journal Information:
Cardiovascular and Interventional Radiology, Journal Name: Cardiovascular and Interventional Radiology Journal Issue: 6 Vol. 31; ISSN 0174-1551; ISSN CAIRDG
Country of Publication:
United States
Language:
English

Similar Records

Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm
Journal Article · Thu Mar 31 23:00:00 EST 1994 · AJNR. American Journal of Neuroradiology; (United States) · OSTI ID:6552900

Brain SPECT and transcranial Doppler (TCD) evaluation of the effects of intra-arterial papaverine for cerebral vasospasm
Journal Article · Sun May 01 00:00:00 EDT 1994 · Journal of Nuclear Medicine · OSTI ID:197931

Restenosis After Balloon Angioplasty for Cerebral Vasospasm
Journal Article · Sun Mar 15 00:00:00 EDT 2009 · Cardiovascular and Interventional Radiology · OSTI ID:21450291